XM无法为美国居民提供服务。
S
S

Sanofi


市场新闻

France corporate earnings week ahead

DIARY-France corporate earnings week ahead Oct 18 (Reuters) - Diary of France (.FCHI) corporate earnings for the week ahead FRANCE EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 24-Oct-2024 BMO DAST.PA Dassault Systemes SE Q3 2024 Dassault Systemes SE Earnings Release 24-Oct-2024 05:30 ORAN.PA Orange SA Q3 2024 Orange SA Earnings Release 25-Oct-2024 05:30 SASY.PA Sanofi SA Q3 2024 Sanofi SA Earnings Release ** All times are listed in AMC - 'After market close', or BMO - 'Before
D
O
S
F

Financial Times - Oct 18

PRESS DIGEST- Financial Times - Oct 18 Oct 18 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - EY slims workforce for first time in 14 years - Sanofi joins rivals investing in nuclear cancer treatment - EU considers including Elon Musk's business empire to calculate potential X fine - UK plans to place 'buy now, pay later' lenders under FCA rules - UK explores plans for new rail line as
S

Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)

CORRECTED-Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17) Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory infections, not all lower respiratory infections Oct 17 (Reuters) - Merck MRK.N said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial virus (RSV)-associated infections in infants.
A
P
S
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Snam, BP, Novo Nordisk, Pony AI; Updates Zuora Oct 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** BP BP.L is considering selling a minority stake in its offshore wind business, according to four sources with knowledge of the matter, the latest effort by CEO Murray Auchincloss to scale back the energy company's focus on renewables.
E
L
S
S
S
P

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Zuora, LVMH, PAI Partners, CSN, Sanofi, PPG Industries, Fuji Soft Oct 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Fuji Soft 9749.T founder and shareholder Hiroshi Nozawa said in a letter to the company, seen by Reuters, that he supports U.S.
L
S
S
P

Sanofi 'surprised' by PAI Partners' raised bid for Opella unit

UPDATE 3-Sanofi 'surprised' by PAI Partners' raised bid for Opella unit PAI Partners seeks to outbid CD&R for Opella stake Sanofi's revised bid valid until Sunday night, source says Company says new offer came outside regular process Unions fear job losses, call for strike at Sanofi's plants Updates with reaction from Sanofi to the new offer in paragraphs 1-6 PARIS, Oct 17 (Reuters) - French drugmaker Sanofi SASY.PA said on Thursday it was "surprised" by a renewed, higher offer for its consumer
S

PAI Partners makes higher offer for Sanofi's Opella, says Le Monde

PAI Partners makes higher offer for Sanofi's Opella, says Le Monde PARIS, Oct 17 (Reuters) - French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's SASY.PA consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival Clayton Dubilier & Rice (CD&R). Sanofi said last week it was in talks with CD&R for the sale of a 50% stake in Opella.
S

Sanofi, Orano Join Forces To Develop Next-Generation Radioligand Medicines

BRIEF-Sanofi, Orano Join Forces To Develop Next-Generation Radioligand Medicines Oct 17 (Reuters) - Sanofi SA SASY.PA : PRESS RELEASE: SANOFI AND ORANO JOIN FORCES TO DEVELOP NEXT-GENERATION RADIOLIGAND MEDICINES SANOFI AND ORANO TO INVEST IN NEW ENTITY FOR RADIOLIGAND THERAPIES TO INVEST €300 MILLION FOR 16% STAKE IN NEW ENTITY Source text for E
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Eiffage, Advent International, Manara Minerals, Saba Infraestructuras Oct 16 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 2 000 GMT on Wednesday: * * Spanish parking operator Saba Infraestructuras will be integrated into Belgium-based Interparking after their main shareholders agreed to a merger, the companies said in a joint statement on Wednesday.
A
B
E
O
S
T
V
B

Goldman, Citi among 22 banks on CD&R’s buyout of Sanofi unit - Bloomberg News

MEDIA-Goldman, Citi among 22 banks on CD&R’s buyout of Sanofi unit - Bloomberg News -- Source link: https://tinyurl.com/kk8h626c -- Note: Reuters has not verified this story and does not vouch for its accuracy
B
B
C
G
S
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: El Al, CSN, Manara Minerals, Sanofi, KKR Oct 16 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 1330 GMT on Wednesday: ** KKR & Co KKR.N is set to launch the sale of Singapore-based Goodpack in a deal that could value the provider of shipping containers and logistics services at around $1.8 billion, people with knowledge of the matter said.
B
O
S
V
B

US FDA pauses Novavax's trial of combo flu shot on safety concerns

UPDATE 4-US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns Adds analyst comment in paragraphs 7 and 11; Sanofi's response in paragraph 10 By Bhanvi Satija Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's NVAX.O COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage, the company said on Wednesday.
P
S

Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration

BRIEF-Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration Oct 16 (Reuters) - Exscientia PLC EXAI.O : EXSCIENTIA ACHIEVES MILESTONES FOR TWO PROGRAMMES IN SANOFI COLLABORATION Source text for Eikon: ID:nBw445cd0a Further company coverage: EXAI.O
S

Sanofi workers in France to strike over sale of consumer health unit, union official says

UPDATE 2-Sanofi workers in France to strike over sale of consumer health unit, union official says Adds company statement in paragraphs 8-9, analyst note in paragraph 10 PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi SASY.PA to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health arm, adding to complications around a deal estimated at about $16 billion.
S

Workers at Sanofi to strike to protest consumer health unit sale, union official says

Workers at Sanofi to strike to protest consumer health unit sale, union official says PARIS, Oct 16 (Reuters) - France's CGT and CFDT unions have called on workers at pharma company Sanofi SASY.PA to strike from Thursday to show their protest against a planned sale of a controlling stake in the firm's consumer health arm, a union official said on Wednesday.
S

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch Oct 16 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. ASML ASML.AS In a video interview on Q3 earnings, group CFO said it expects China to come in at around 20% of the Dutch semiconductor equipment maker's total revenue in 2025. CREDIT AGRICOLE CAGR.PA French bank Credit Agricole said it is planning to buy a 50% stake in Chinese company GAC Finance L
C
I
L
R
S
V
A
F
N
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds EDP, Fertiglobe, Opella, Credit Agricole and Frontier Communications Oct 15 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 2 000 GMT on Tuesday: * * Some of Frontier Communications' FYBR.O largest shareholders are concerned about its planned $9.6 billion takeover by Verizon Communications VZ.N , with its second-largest investor planning to vote against the deal, three sources familiar with the firm's plans said
C
S
V

France considering stake in Sanofi's Opella, minister says

France considering stake in Sanofi's Opella, minister says PARIS, Oct 15 (Reuters) - France is considering taking a stake in Sanofi's SASY.PA Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker's plans to sell a 50% stake in Opella to a U.S. private equity firm could result in job cuts. Trade unions and opposition politicians have expressed unease over Sanofi's decision to sell a controlling 50% stake in Opella - whose brands include painkiller Doliprane
S

CD&R $17 bln French deal may hinge on big retreat

BREAKINGVIEWS-CD&R $17 bln French deal may hinge on big retreat The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, Oct 15 (Reuters Breakingviews) - In battle sometimes the best way forward is to retreat. Clayton Dubilier & Rice may have to follow that thinking as the buyout shop tries to clinch a 15 billion euro deal for Sanofi’s SASY.PA consumer unit amid rising concerns from French politicians.
S

Amgen falls as Truist downgrades to 'hold' on competition for experimental skin disease drug

BUZZ-Amgen falls as Truist downgrades to 'hold' on competition for experimental skin disease drug ** Shares of drugmaker Amgen AMGN.O fall 1% to $324.95 ** Truist Securities downgrades stock to "hold" from "buy", citing "extremely competitive" landscape for an experimental drug to treat atopic dermatitis or eczema ** Brokerage also raises PT to $33
A
R
S



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明